Modern Medicine

Moxonidine for Hypertension in Metabolic Syndrome

The centrally acting antihypertensive, moxonidine, reduces blood pressure (BP) in mild-to-moderate hypertensive patients as effectively as most first-line antihypertensives when used as monotherapy, and also in combination with other antihypertensive agents. It improves the metabolic profile in patients with hypertension and diabetes mellitus or impaired glucose tolerance, is well tolerated, has a low potential for drug interactions and may be administered once daily in most patients.

Modern Medicine – Issue 3 2021

Glycosaminoglycan Replacement Targets Painful Bladder

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating chronic disease characterised by discomfort or recurrent abdominal and pelvic pains in the absence of urinary tract infections. Although the aetiology is unknown, there is increasing evidence that increased bladder layer permeability is linked to the symptoms of interstitial cystitis or painful bladder.

Modern Medicine – Issue 3 2021

Establishing an Accurate Allergy Diagnosis is Key

Allergic diseases are amongst the most prevalent diseases worldwide and the burden of these diseases continues to increase. An accurate diagnosis coupled with optimal therapy requires the use of appropriate tests to confirm the allergen sensitisation and detailed information about exposure to the putative allergen.

Modern Medicine – Issue 3 2021

Towards Definitive Management of Allergic Rhinitis Best use of new and established therapies

Towards Definitive Management of Allergic Rhinitis
Best use of new and established therapies

Allergic rhinitis (AR) is an inflammatory disease of the nasal mucosa impacting almost 25% of Canadians and up to 38.5% of South Africans. The standard of care for AR includes a treatment plan that takes into account patient preferences, the severity of the disease, and most essentially involves a shared decision-making process between patient and provider. This is a shortened version of the original open access article.

Modern Medicine – Issue 3 2021

Running a Profitable Healthcare Practice

With excellent patient outcomes and a solid reputation, Michael’s healthcare practice seemed to be thriving. As his practice grew, so did the time spent on managing the accompanying admin. He was spending so much energy on these functions that he couldn’t focus on improving treatment service for his patients.

Modern Medicine – Issue 3 2021

Unpacking the Mind-body Connection to Health

“According to the mind–body or biopsychosocial paradigm, which supersedes the older biomedical model, there is no real division between mind and body because of networks of communication that exist between the brain and neurological, endocrine and immune systems.” – Oakley Ray, Professor Emeritus of Psychology, Psychiatry and Pharmacology at Vanderbilt University, USA.

Modern Medicine – Issue 3 2021

Modern Medicine – Issue 2, 2021

The latest edition of Modern Medicine is now available for you to read. We have some great articles featured in this edition to give you something to read over the easter break period; topics covered include:

Ethics (CPD) – Commoditisation in Healthcare
Pulmonology (CPD) – Paediatric Asthma
Cardiology – 2020 Heart Failure Guidelines
Gastroenterology (CPD) – Is It IBD?
… and many more !

Also, a reminder that, not only do we have CPD questions available within the magazine itself, we also have an online CPD portal that allows you to score even more points by simply completing your test online

Modern Medicine, the journal that’s with you wherever you go.

Managing Residual Cardiovascular Risk with Fenofibrate

Although statins are the first-line treatment for hyperlipidaemia, risk of cardiovascular disease remains even with treatment. Fibrates such as fenofibrate have been shown to have a role in further reducing cardiovascular risk, especially in cases of metabolic syndrome and severe hyperlipidaemia and dyslipidaemia.

Modern Medicine – Issue 2 2021

How to Optimise Therapy for heart failure with reduced ejection fraction

The prognosi s for patients with heart failure is poor, with high rates of hospitalisation and mortality. It is essential to optimise pharmacotherapy and device therapies that improve the prognosis for patients with heart failure with reduced ejection fraction.

Modern Medicine – Issue 2 2021

Pre-eclampsia Prediction and Prevention is Key

Pre-eclampsia (PE) is a complex pregnancy disease that affects the safety of 3% to 5% of pregnancies worldwide and is one of the important causes of maternal, foetal and neonatal deaths. To date, the pathogenesis of PE is not yet clear. Due to the lack of specific effective treatments for PE, its prediction and prevention are particularly important.

Modern Medicine – Issue 2 2021